GHRP-2 (5mg Vial)

01 · At a glance

Quickstart Highlights

GHRP-2 (Growth Hormone-Releasing Peptide-2) is a synthetic hexapeptide that stimulates potent, dose-dependent growth hormone release by activating ghrelin receptors [1] . Clinical studies predominantly employ once-daily subcutaneous administration to elicit robust pulsatile GH release while minimizing receptor desensitization [2] [3] . This educational protocol presents a practical gradual titration approach with clear insulin-syringe measurements.

02 · Dosing & reconstitution

Dosing & Reconstitution Guide

A practical calculator-ready setup based on the imported protocol reference. Use these values as a math starting point, then verify every entry against your own vial, diluent, and professional guidance.

Standard / Gradual Approach (3 mL = ~1.67 mg/mL)

100–300 mcg once daily subcutaneously.

Reconstitution Steps

1. Draw 3.0 mL bacteriostatic water with a sterile syringe.
2. Inject slowly down the vial wall; avoid foaming.
3. Gently swirl or roll until completely dissolved (do not shake).
4. Label and refrigerate at 2–8 °C (35.6–46.4 °F) , protected from light.

03 · What you'll need

Supplies Needed

Keep this as a planning checklist. TNHL does not sell or verify supplies on this page, and no supplier quality claims are made here.

Protocol Overview

• Goal: Stimulate endogenous growth hormone secretion through ghrelin receptor activation [1] .
• Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
• Dose Range: 100–300 mcg daily with gradual titration; higher doses show dose-dependent responses but may offer limited added benefit with routine use [4] .
• Reconstitution: 3.0 mL per 5 mg vial (~1.67 mg/mL) for accurate unit measurements.
• Storage: Lyophilized frozen; reconstituted refrigerated (use within 2–3 weeks for optimal integrity).

Dosing Protocol

• 100–300 mcg once daily subcutaneously.
• Inject once daily subcutaneously. This once-daily schedule balances efficacy with receptor recovery time, avoiding the rapid attenuation seen with frequent dosing [3] . Administering in the evening may capitalize on nocturnal GH rhythms. For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.
• If values change, rerun the calculator and update the protocol so future logs match the active plan.

Storage Instructions

• Lyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) .
• Storage: Lyophilized frozen; reconstituted refrigerated (use within 2–3 weeks for optimal integrity).
• Keep mixed and unmixed items clearly labeled so inventory and dose logs stay accurate.

04 · Good to know

Important Notes

• Practical considerations for consistency and safety.
• Use new sterile insulin syringes for each injection; dispose in a sharps container.
• Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation and prevent lipodystrophy [13] .
• Very frequent dosing (e.g., every 2 hours) can cause progressive attenuation due to acute tachyphylaxis [3] ; once-daily administration avoids this issue.
• Multiple daily injections (2–3×) have been explored but require strict adherence and may offer limited added benefit [5] [6] .
• Document daily dose and site rotation to maintain consistency.

05 · How it works

How This Works

GHRP-2 (Growth Hormone-Releasing Peptide-2) is a synthetic hexapeptide that stimulates potent, dose-dependent growth hormone release by activating ghrelin receptors [1] .

Clinical studies predominantly employ once-daily subcutaneous administration to elicit robust pulsatile GH release while minimizing receptor desensitization [2] [3] .

This educational protocol presents a practical gradual titration approach with clear insulin-syringe measurements.

The library page pairs that educational context with calculator-ready vial math, so users can understand the protocol structure and then track their own entered values in one place.

06 · Daily habits

Lifestyle Factors

• Keep meals, training, sleep, and recovery notes in the journal so trends are easier to review.
• Track body metrics only if they are relevant to the user's goal and approved data sources.
• Use consistent timing and logging habits so adherence data is meaningful.

07 · What to expect

Potential Benefits & Side Effects

• GHRP-2 observations should be recorded conservatively: expected research endpoints, tolerability notes, injection-site reactions when applicable, sleep, appetite, energy, mood, and any adverse or unusual response.
• This section is not a claim of therapeutic benefit.

08 · Technique

Injection Technique

09 · Evidence

References